The Department of Pharmaceuticals, Government of India, organised an Industry dialogue on the Promotion of Research and Innovation in the Pharma-MedTech Sector (PRIP) Scheme in Mumbai. The event served as a platform for industry leaders, associations and research institute from Indian Council for Medical Research (ICMR), Council of Scientific and Industrial Research (CSIR) and National Institute of Pharmaceutical Education and Research (NIPERs) to engage in discussions on strengthening industry-academia linkages, fostering collaboration and leveraging government initiatives to accelerate R&D and commercialise innovative solutions in the pharmaceutical and medical technology sectors.
In the breakout sessions, industry representatives and other stakeholders gave in-depth feedback regarding research and innovation opportunities, emerging R&D trends, strategies to enhance industry-academia collaboration. Useful suggestions were made regarding streamlining regulatory pathways, maximising funding opportunities and scaling up innovative research initiatives to drive the sector’s growth.
Industry stakeholders were encouraged to submit their feedback and project details through the Expression of Interest (EoI) hosted on the Department of Pharmaceuticals website, which will be open till April 7, 2025. This process will help refine the implementation strategy of the PRIP Scheme, ensuring it aligns with industry need and drives sectoral growth.
